Bio-Rad Buys Virtek Biotech Microarray, Robotic Business
HERCULES, Calif., July 2 -- Bio-Rad Laboratories Inc. has acquired the microarray and robotics technologies business of Virtek Biotech Canada Inc., a subsidiary of Virtek Vision International Inc. of Waterloo, Ontario. Bio-Rad paid approximately $7 million to acquire assets. Bio-Rad will hire employees from this group and expects operations to continue in Canada.
"We are very excited about this acquisition," said Norman Schwartz, Bio-Rad vice president and Life Science Group manager. "It is a natural extension of our DNA- and proteome-based product lines, augmenting our existing gene transfer, amplification and imaging products. We expect microarray technologies to become a standard method used in molecular biology laboratories, and this gives us an excellent entree into this fast growing market."
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024